Impact of a formulary switch from ticarcillin-clavulanate to piperacillin-tazobactam on colonization with vancomycin-resistant enterococci

American Journal of Infection Control

Volumn 32, Issue 8, 2004, Pages 462-469

  Winston, Lisa G ^a,b   Charlebois, Edwin D ^a   Pang, Szekim ^a   Bangsberg, David R ^a   Perdreau Remington, Francoise ^a   Chambers III, Henry F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; CEFTRIAXONE; CILASTATIN PLUS IMIPENEM; CLINDAMYCIN; MEROPENEM; METRONIDAZOLE; PIPERACILLIN PLUS TAZOBACTAM; TIMENTIN; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; BACTERIUM CULTURE; DRUG FORMULARY; ENTEROCOCCUS; FEMALE; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; MALE; MULTIVARIATE ANALYSIS; SURVIVAL; TIME SERIES ANALYSIS;

ANTI-BACTERIAL AGENTS; CARRIER STATE; CLAVULANIC ACIDS; CROSS INFECTION; ENTEROCOCCUS FAECIUM; FEMALE; FORMULARIES, HOSPITAL; GASTROINTESTINAL TRACT; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PENICILLANIC ACID; PIPERACILLIN; PROSPECTIVE STUDIES; RISK FACTORS; TICARCILLIN; TIME FACTORS; VANCOMYCIN RESISTANCE;

EID: 9644281222     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2004.07.004     Document Type: Article

References (18)

1. B.E. Murray Vancomycin-resistant enterococcal infections N Engl J Med 342 2000 710 721
2. E.M. Jochimsen, L. Fish, K. Manning, S. Young, D.A. Singer, and R. Baker Control of vancomycin-resistant enterococci at a community hospital: efficacy of patient and staff cohorting Infect Control Hosp Epidemiol 20 1999 106 109
3. M.A. Montecalvo, W.R. Jarvis, J. Uman, D.K. Shay, C. Petrullo, and K. Rodney Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting Ann Intern Med 131 1999 269 272
4. B. Ostrowsky, J.T. Steinberg, B. Farr, A.H. Sohn, R.L. Sinkowitz-Cochran, and W.R. Jarvis Reality check: should we try to detect and isolate vancomycin-resistant enterococci patients? Infect Control Hosp Epidemiol 22 2001 116 119
5. S.K. Fridkin, J.R. Edwards, J.M. Courval, H. Hill, F.C. Tenover, and R. Lawton The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units Ann Intern Med 135 2001 175 183
6. J. Quale, D. Landman, G. Saurina, E. Atwood, V. DiTore, and K. Patel Manipulation of a hospital antimicrobial formulary to control an outbreak of vancomycin-resistant enterococci Clin Infect Dis 23 1996 1020 1025
7. E. Lautenbach, L.A. LaRosa, A.M. Marr, I. Nachamkin, W.B. Bilker, and N.O. Fishman Changes in the prevalence of vancomycin-resistant enterococci in response to antimicrobial formulary interventions: impact of progressive restrictions on use of vancomycin and third-generation cephalosporins Clin Infect Dis 36 2003 440 446
8. C.J. Donskey, J.R. Schreiber, M.R. Jacobs, R. Shekar, R.A. Salata, and S. Gordon A polyclonal outbreak of predominantly VanB vancomycin-resistant enterococci in northeast Ohio. Northeast Ohio Vancomycin-Resistant Enterococcus Surveillance Program Clin Infect Dis 29 1999 573 579
9. C.J. Donskey, J.A. Hanrahan, R.A. Hutton, and L.B. Rice Effect of parenteral antibiotic administration on the establishment of colonization with vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract J Infect Dis 181 2000 1830 1833
10. J.R. Le Gall, S. Lemeshow, and F. Saulnier A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study JAMA 270 1993 2957 2963
11. L.G. Winston, S. Pang, B.L. Haller, M. Wong, H.F. Chambers III, and F. Perdreau-Remington API 20 Strep System may incorrectly speciate enterococci with low level resistance to vancomycin Diagn Microbiol Infect Dis 48 2004 287 288
12. M.J. Bonten, S. Slaughter, A.W. Ambergen, M.K. Hayden, J. van Voorhis, and C. Nathan The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable Arch Intern Med 158 1998 1127 1132
13. L.G. Winston, D.R. Bangsberg, H.F. Chambers III, S.C. Felt, J.I. Rosen, and E.D. Charlebois Epidemiology of vancomycin-resistant Enterococcus faecium under a selective isolation policy at an urban county hospital Am J Infect Control 30 2002 400 406
14. C.J. Donskey, T.K. Chowdhry, M.T. Hecker, C.K. Hoyen, J.A. Hanrahan, and A.M. Hujer Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients N Engl J Med 343 2000 1925 1932
15. C.J. Donskey, J.A. Hanrahan, R.A. Hutton, and L.B. Rice Effect of parenteral antibiotic administration on persistence of vancomycin-resistant Enterococcus faecium in the mouse gastrointestinal tract J Infect Dis 180 1999 384 390
16. G.A. Papanicolaou, B.R. Meyers, J. Meyers, M.H. Mendelson, W. Lou, and S. Emre Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: risk factors for acquisition and mortality Clin Infect Dis 23 1996 760 766
17. S.L. Orloff, A.M. Busch, A.J. Olyaei, C.L. Corless, K.G. Benner, and K.D. Flora Vancomycin-resistant enterococcus in liver transplant patients Am J Surg 177 1999 418 422
18. B.E. Ostrowsky, W.E. Trick, A.H. Sohn, S.B. Quirk, S. Holt, and L.A. Carson Control of vancomycin-resistant enterococcus in health care facilities in a region N Engl J Med 344 2001 1427 1433